Dural Arteriovenous Fistulas Treatment Market Research Report- Forecast till 2027

Dural Arteriovenous Fistulas Treatment Market Information: By Type (Type I, Type II, Type III), Treatment (Surgery, Stereotactic Radiosurgery, Embolization), End User (Hospitals & Clinics, Ambulatory Surgical Centers) - Forecast till 2027

ID: MRFR/Pharma/3170-HCR | February 2021 | Region: Global | 95 pages

Dural Arteriovenous Fistulas Treatment Market Scenario


Dural arteriovenous fistulas (DAVF) is caused by abnormal connections between arteries and veins in a protective membrane on the outer layer of the brain and spine; it is a rare disease. These abnormal blood vessels divert blood from the normal paths. If the volume of diverted blood flow is large, tissue downstream may not receive an adequate blood and oxygen supply. The symptoms vary, depending on the location of fistulae. Headaches are among the most common symptoms with all types of DAVFs. Other symptoms include visual problems, ringing in ears, heart strokes, and others.


Increasing prevalence of brain injury and neurological disorders, increasing investment in biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the dural arteriovenous fistulas treatment market. Moreover, favorable reimbursement policies, increased applications, and significant investments in the development of advance technologies for the treatment methods likely to fuel the dural arteriovenous fistulas treatment market growth during the forecast period 2017-2023.


As per the Centers for Disease Control and Prevention in 2014, about 2.8 million TBI-related Emergency Department (ED) visits, hospitalizations, and deaths occurred in the United States. TBI (traumatic brain injury) contributed to the deaths of nearly 50,000 people. It was diagnosed in over 282,000 hospitalized cases and over 2.5 million ED visits.  These consisted of TBI alone or TBI in combination with other injuries. Adults aged over 75 years have the highest rates of TBI-related hospitalization and deaths.


According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of gastrointestinal disorders, or cancers, and is expected to increase further over the coming years.


However, higher cost of these treatment procedure may hamper the dural arteriovenous fistulas treatment market growth during the corresponding period.


The dural arteriovenous fistulas treatment market is expected to grow at a CAGR of ~ 7.68 % during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Figure: Global Dural Arteriovenous Fistulae Treatment Market, by Region Market Share, 2016 (%) Dural Arteriovenous Fistulas Treatment Market

Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.


On the basis of type, the dural arteriovenous fistulas treatment market is segmented into type I, type II, and type III.


On the basis of application, the dural arteriovenous fistulas treatment market is segmented into surgery, stereotactic radiosurgery, embolization, and others.


On the basis of end user, the dural arteriovenous fistulas treatment market is segmented into hospitals & clinics, ambulatory surgical centers, and others. 


Regional Analysis


The Americas dominates the dural arteriovenous fistulas treatment market owing to developing  technology, increasing cases of brain injury, rising prevalence of neurological disorders, growing healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the dural arteriovenous fistulas treatment market. It is expected that the government support for research & development and availability of funds for research may drive the market in European region over the review period.


Asia Pacific is the fastest growing dural arteriovenous fistulas treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries such as China, India, Japan, and South Korea projected to emerge as the fastest growing market across the globe. Furthermore, increasing demand for the neurological treatment may lead to the use of advanced equipment, which, in turn, will increase the growth of the dural arteriovenous fistulas treatment market in the region.


On the other hand, the Middle East and Africa holds the least share of the market due to limited medical facilities, lack of funds for research and development, and poor political conditions, especially, in Africa.


Key Players


Some of key the players in the dural arteriovenous fistulas treatment market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited. 


Research Methodology
Dural Arteriovenous Fistulas Treatment Market-


Sources: Annual reports, Press release, White paper, and Company presentation


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.68 % (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of brain injury and neurological disorders
  • Increasing investment in biotechnology and pharmaceutical industries in R&D
  • Rising need for the better treatment methods


  • Frequently Asked Questions (FAQ) :


    Dural arteriovenous fistulae treatment market is projected to grow at approximately 7.68% CAGR during the assessment period (2020-2027).

    Increasing prevalence of brain injury & neurological disorders, rising per capita healthcare expenditure, and increasing investment in biotechnology & pharmaceutical industries.

    Higher cost and reported cases of side effects associated with these treatment procedures are major growth impeders for the global dural arteriovenous fistulae treatment market.

    North America holds the largest share in the global dural arteriovenous fistulae treatment market, followed by Europe and the Asia Pacific, respectively.

    BD (U.S.), B. Braun Melsungen AG (Germany), Medtronic (U.S.), Cook (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited, are some of the top players operating in the global dural arteriovenous fistulae treatment market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Dural Arteriovenous Fistulae Treatment Market, by Type

    6.1 Introduction

    6.2 Type I

    6.2.1 Market Estimates & Forecast, 2020- 2027

    6.3 Type II

    6.3.1 Market Estimates & Forecast, 2020 -2027

    6.4 Type III

    6.4.1 Market Estimates & Forecast, 2020 -2027¬¬

    Chapter 7. Global Dural Arteriovenous Fistulae Treatment Market, by Treatment

    7.1 Introduction

    7.2 Surgery

    7.2.1 Market Estimates & Forecast, 2020 -2027

    7.3 Stereotactic radiosurgery

    7.3.1 Market Estimates & Forecast, 2020 -2027

    7.4 Embolization

    7.4.1 Market Estimates & Forecast, 2020 -2027

    Chapter 8. Global Dural Arteriovenous Fistulae Treatment Market, by End User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.2.1 Market Estimates & Forecast, 2020 -2027

    8.3 Ambulatory Surgical Centers

    8.2.2 Market Estimates & Forecast, 2020 -2027

    8.4 Others

    Chapter 9. Global Dural Arteriovenous Fistulae Treatment Market, by Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic of Korea

    9.4.6 Rest of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest of the Middle East & Africa

    Chapter 10. Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11. Company Profiles

    11.1 BD

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 Medtronic

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 B. Braun Melsungen AG

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 Cook

    11.4.1 Company Overview

    11.4.2 Product/Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Teleflex Incorporated

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial overview

    11.5.4 Key Developments

    11.5.5 SWOT Analysis

    11.6 Fresenius Medical Care AG & Co. KGaA

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.6.5 SWOT Analysis

    11.7 NxStage Medical, Inc.

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    Chapter 12. MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs of the Market

    12.2 Key Companies to Watch

    12.3 Prediction of Medical Devices industry

    Chapter 13. Appendix


    LIST OF TABLES

    Table 1 Dural Arteriovenous Fistulae Treatment Industry Synopsis, 2020 -2027

    Table 2 Global Dural Arteriovenous Fistulae Treatment Market Estimates and Forecast, 2020 -2027, (USD Million)

    Table 3 Global Dural Arteriovenous Fistulae Treatment Market by Region, 2020 -2027, (USD Million)

    Table 4 Global Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 5 Global Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 6 Global Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 7 North America Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 8 North America Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 9 North America Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 10 US Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 11 US Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 12 US Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 13 Canada Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 14 Canada Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 15 Canada Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 16 South America Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 17 South America Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 18 South America Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 19 Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 20 Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 21 Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 22 Western Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 23 Western Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 24 Western Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 25 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 26 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 27 Eastern Europe Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 28 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 29 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 30 Asia Pacific Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)

    Table 31 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by Type, 2020 -2027, (USD Million)

    Table 32 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by Treatment, 2020 -2027, (USD Million)

    Table 33 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market by End Users, 2020 -2027, (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Dural Arteriovenous Fistulae Treatment Market

    Figure 3 Segmentation Market Dynamics for Global Dural Arteriovenous Fistulae Treatment Market

    Figure 4 Global Dural Arteriovenous Fistulae Treatment market Share, by Type 2020

    Figure 5 Global Dural Arteriovenous Fistulae Treatment market Share, by Treatment 2020

    Figure 6 Global Dural Arteriovenous Fistulae Treatment Market Share, by End Users, 2020

    Figure 7 Global Dural Arteriovenous Fistulae Treatment Market Share, by Region, 2020

    Figure 8 North America Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020

    Figure 9 Europe Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020

    Figure 10 Asia Pacific Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020

    Figure 11 Middle East & Africa Dural Arteriovenous Fistulae Treatment Market Share, by Country, 2020

    Figure 12 Global Dural Arteriovenous Fistulae Treatment Market: Company Share Analysis, 2020 (%)

    Figure 13 BD: Key Financials

    Figure 14 BD: Segmental Revenue

    Figure 15 BD: Geographical Revenue

    Figure 16 Medtronic: Key Financials

    Figure 17 Medtronic: Segmental Revenue

    Figure 18 Medtronic: Geographical Revenue

    Figure 19 B. Braun Melsungen AG: Key Financials

    Figure 20 B. Braun Melsungen AG: Segmental Revenue

    Figure 21 B. Braun Melsungen AG: Geographical Revenue

    Figure 22 Cook: Key Financials

    Figure 23 Cook: Segmental Revenue

    Figure 24 Cook: Geographical Revenue

    Figure 25 Teleflex Incorporated: Key Financials

    Figure 26 Teleflex Incorporated: Segmental Revenue

    Figure 27 Teleflex Incorporated: Geographical Revenue

    Figure 28 Fresenius Medical Care AG & Co. KGaA.: Key Financials

    Figure 29 Fresenius Medical Care AG & Co. KGaA: Segmental Revenue

    Figure 30 Fresenius Medical Care AG & Co. KGaA.: Geographical Revenue

    Figure 31 NxStage Medical, Inc.: Key Financials

    Figure 32 NxStage Medical, Inc.: Segmental Revenue

    Figure 33 NxStage Medical, Inc.: Geographical Revenue